Use of coiled-coil structural scaffold to generate structure-specific peptides
CA 2410604 A1 · Owner: Cytovax Biotechnologies, Inc. · Inventors: Hodges, Robert S.; Houston, Michael E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to the use of a coiled-coil structural scaffold to generate structure-specific peptides, including synthetic peptides derived from naturally occurring proteins of various origin. The structure of the synthetic peptides utilizes a scaffold of heptad repeat units into which epitopes from coiled- coil regions of native proteins are spliced. In particular, the synthetic peptides may be based on microbial proteins especially surface proteins, which occur naturally in the coiled-coil form such as pneumococcal surface proteins A and C. The synthetic peptides are immunogenic and can be used to elicit an immune response in an animal. Accordingly, they are useful as …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 14, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.